Avicura Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.42 M
- Company Age 5 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 118.19%
- Profit Growth 61.23%
- Ebitda 128.96%
- Net Worth 111.39%
- Total Assets 33.58%
About Avicura Pharmaceuticals
Avicura Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 January 2020 (Five years 7 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.42 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Bhadane, Sitaram Shinde, and Vishal Surve serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24119MH2020PTC336467
- Company No.
336467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Avicura Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Bhadane  | Additional Director | 02-Aug-2024 | Current |
| Sitaram Shinde | Director | 22-Jan-2020 | Current |
| Vishal Surve | Director | 22-Jan-2020 | Current |
Financial Performance of Avicura Pharmaceuticals.
Avicura Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 118.19% increase. The company also saw a substantial improvement in profitability, with a 61.23% increase in profit. The company's net worth Soared by an impressive increase of 111.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avicura Pharmaceuticals?
Unlock access to Avicura Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jupiter Feeds India Private LimitedSitaram Shinde is a mutual person
- Bionex Vetcare Private Limited
Vishal Surve is a mutual person
- Vetecura Life Sciences Private Limited
Vishal Surve is a mutual person
- Adyukta Alliance Private Limited
Vishal Surve is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avicura Pharmaceuticals?
Unlock and access historical data on people associated with Avicura Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avicura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avicura Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.